Browse Category

Stock Market News 23 December 2025

Visa Stock News Today (Dec. 23, 2025): Holiday Spending Data, Stablecoin Settlement Push, and Wall Street Forecasts for V

Visa Stock News Today (Dec. 23, 2025): Holiday Spending Data, Stablecoin Settlement Push, and Wall Street Forecasts for V

Visa Inc. (NYSE: V) stock is back in the spotlight on Dec. 23, 2025, as fresh holiday spending data adds new color to the consumer-demand picture—and as investors weigh the payments giant’s fast-moving strategy in stablecoin settlement and AI-driven “agentic commerce.” As of early afternoon Tuesday, Visa shares were modestly higher, trading around $354 (roughly +0.5% on the day), with the company’s investor relations quote page listing a 52-week range of about $299 to $375. Visa Investor Relations Below is what’s driving headlines around Visa stock today, plus the forecasts and key debates shaping the outlook into 2026. Visa stock
ZIM Integrated Shipping (ZIM) Stock Surges on Competing Buyout Proposals: Latest News, Analyst Targets, Dividend, and 2026 Shipping Outlook

ZIM Integrated Shipping (ZIM) Stock Surges on Competing Buyout Proposals: Latest News, Analyst Targets, Dividend, and 2026 Shipping Outlook

December 23, 2025 — Shares of ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) jumped Tuesday after the company disclosed that its board has received multiple competing proposals to acquire the company’s outstanding shares, escalating a strategic review that has been underway for months. ZIM Investors+2Benzinga+2 As of 17:15 UTC on Tuesday, Dec. 23, ZIM traded at $20.96, after touching an intraday high of $22.35 and low of $20.72 on unusually heavy volume. What’s driving the move is simple in headline form—“buyout proposals”—but the investor calculus is more complicated: ZIM sits at the intersection of (1) a potentially high-stakes corporate event
NexGen Energy Stock (NXE) News and Forecast for Dec. 23, 2025: Final Rook I Hearings Loom as Analysts Stay Bullish

NexGen Energy Stock (NXE) News and Forecast for Dec. 23, 2025: Final Rook I Hearings Loom as Analysts Stay Bullish

Dec. 23, 2025 — NexGen Energy Ltd. (TSX: NXE | NYSE: NXE | ASX: NXG) is back in the spotlight as investors weigh a familiar uranium-developer question with very unfamiliar stakes: how close is “close” to a construction decision? TMX Newsfile+1 For NexGen, that question largely funnels into one major catalyst: the Canadian Nuclear Safety Commission (CNSC) process for its 100%-owned Rook I Project in Saskatchewan’s uranium-rich Athabasca Basin. Part 1 of the CNSC hearing took place on Nov. 19, 2025, and Part 2 is scheduled for Feb. 9–13, 2026, after which the Commission will make its approval determination. Canadian
Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics Inc. (NASDAQ: GPCR) is ending 2025 in the middle of one of biotech’s hottest battlegrounds: oral weight-loss medicines. As of Dec. 23, 2025, GPCR shares were trading around $67.50 in U.S. session data, after a volatile stretch driven by blockbuster obesity-trial headlines, a major equity financing, and a wave of analyst price-target updates. Below is a comprehensive roundup of the latest news, forecasts, and analysis available as of 23.12.2025, and what investors are watching next. What is Structure Therapeutics, and why does GPCR trade like a headline detector? Structure Therapeutics is a clinical-stage biopharmaceutical company developing oral small-molecule
Merck (MRK) Stock News and Forecasts for Dec. 23, 2025: TrumpRx Pricing Deal, FDA Fast-Track Vouchers, and Wall Street’s Latest Targets

Merck (MRK) Stock News and Forecasts for Dec. 23, 2025: TrumpRx Pricing Deal, FDA Fast-Track Vouchers, and Wall Street’s Latest Targets

Merck & Co., Inc. (NYSE: MRK) is closing in on year-end with a rare mix of policy-driven headlines, regulatory acceleration, and pipeline catalysts that are shaping investor expectations for 2026 and beyond. From a White House-backed drug-pricing framework that offers tariff relief to drugmakers, to the FDA’s fast-track voucher program attaching itself to two Merck assets with blockbuster potential, MRK stock is being evaluated not just on quarterly numbers—but on whether Merck can extend growth beyond Keytruda while navigating intensifying U.S. drug-pricing scrutiny. Reuters+2Reuters+2 Below is a comprehensive, publication-ready roundup of today’s MRK stock action, the key news moving the
Bank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025Bank of AmericaBank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

Bank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025Bank of AmericaBank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

Bank of America Corporation (NYSE: BAC) stock is trading near its recent highs as 2025 winds down, with investors balancing three big forces: a shifting interest-rate outlook, improving Wall Street deal momentum, and a growing stack of analyst upgrades heading into the bank’s next earnings report. As of Tuesday, December 23, 2025, BAC was trading around $55.96, modestly higher on the session, after touching an intraday high near $56.17. Investing.com Below is a full round-up of the latest news, forecasts, and market analysis available as of 23.12.2025, plus the key catalysts that could decide whether Bank of America stock breaks
Hut 8 Corp Stock (HUT) Surges on $7B Google-Backed AI Data Center Deal, Street-High $85 Target, and Fresh Analyst Upgrades

Hut 8 Corp Stock (HUT) Surges on $7B Google-Backed AI Data Center Deal, Street-High $85 Target, and Fresh Analyst Upgrades

Hut 8 Corp (NASDAQ: HUT; TSX: HUT) is back in the market’s spotlight on December 23, 2025, as investors continue to re-rate the company less like a pure-play Bitcoin miner and more like a power-and-data-center platform for the AI era. The stock’s action has been anything but sleepy. After opening sharply lower, shares reversed higher and pushed into the low-to-mid $50s intraday. As of 17:04 UTC on Dec. 23, Hut 8 traded at $53.62, up 6.41% on the day, with an intraday range of $48.02 to $53.86 on roughly 6.7 million shares. So what’s driving the whiplash—and why are analysts
Intel Stock (INTC) News Today: Price, Analyst Forecasts, and What’s Driving Intel Shares on Dec. 23, 2025

Intel Stock (INTC) News Today: Price, Analyst Forecasts, and What’s Driving Intel Shares on Dec. 23, 2025

Intel Corporation (NASDAQ: INTC) is ending 2025 in a familiar place for long-time investors—right at the center of a high-stakes debate about what Intel is supposed to be. Is it a classic CPU giant fighting to regain product leadership? A U.S.-anchored foundry champion meant to rival TSMC? Or both at once? On Tuesday, Dec. 23, 2025, that identity question is colliding with a fresh wave of Wall Street calls, a closely watched Nvidia investment now cleared by U.S. antitrust agencies, and renewed arguments that Intel’s foundry ambitions may be limited by one simple issue: trust. Reuters+2Fudzilla+2 Intel stock price today:
Lionsgate Studios Corp (NYSE: LION) Stock Jumps to New Highs on Dec. 23, 2025: Latest News, Analyst Forecasts, and What’s Driving the Move

Lionsgate Studios Corp (NYSE: LION) Stock Jumps to New Highs on Dec. 23, 2025: Latest News, Analyst Forecasts, and What’s Driving the Move

December 23, 2025 — Lionsgate Studios Corp stock is having a loud day in the market. Shares of Lionsgate Studios Corp (NYSE: LION) traded around $9.06 Tuesday, up roughly 8%–9%, after touching an intraday high near $9.23 (and a low around $8.54). That price action matters because LION has been flirting with (and now pushing beyond) its prior 52-week high around $9.14—a technical milestone that tends to attract momentum traders and forces skeptics to revisit the “this is just a sleepy studio stock” thesis. Lionsgate Investors+1 Below is what’s new as of Dec. 23, 2025, plus the most relevant forecasts
Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

December 23, 2025 — Eli Lilly and Company stock (NYSE: LLY) is holding near record territory as investors digest a fresh twist in the weight-loss drug race: the FDA has cleared Novo Nordisk’s first oral version of Wegovy, intensifying competition right as Lilly pushes its own once-daily pill candidate, orforglipron, toward a potential 2026 approval. As of 15:11 UTC on Tuesday, LLY traded around $1,077, slightly above the prior close, after moving between roughly $1,057 and $1,088 during the session. The backdrop is simple but powerful: the obesity market is expanding fast, and the “next chapter” is about convenience, supply,
Citigroup Stock (NYSE: C): Regulatory Pressure Eases, Shares Hit New 52‑Week High as Wall Street Maps the 2026 Outlook

Citigroup Stock (NYSE: C): Regulatory Pressure Eases, Shares Hit New 52‑Week High as Wall Street Maps the 2026 Outlook

Dec. 23, 2025 — Citigroup, Inc. stock is closing out 2025 with a tailwind that investors have been waiting years to see: meaningful signs that long-running regulatory overhangs are starting to lift. Coming into Tuesday’s session, Citi (NYSE: C) was already riding fresh momentum after a strong Monday rally pushed the shares to a new 52‑week high. MarketWatch The year-end story around Citigroup stock is no longer just about a bank “in turnaround.” It’s increasingly about whether CEO Jane Fraser’s multi-year transformation is finally translating into a cleaner regulatory slate, a simpler operating model, and a clearer path to higher
Costco Stock (COST) Outlook on Dec. 23, 2025: Earnings Beat, Holiday Spending Signals, and Wall Street Forecasts for 2026

Costco Stock (COST) Outlook on Dec. 23, 2025: Earnings Beat, Holiday Spending Signals, and Wall Street Forecasts for 2026

Costco Wholesale Corporation (NASDAQ: COST) is heading into the final stretch of 2025 in a familiar position operationally—strong sales, loyal members, and steady expansion—yet in a less familiar spot in the market: trading close to its 52‑week low after a year of choppy performance. As of Tuesday, Dec. 23, 2025, Costco shares were trading around $853 in late U.S. trading, up modestly on the day. StockAnalysis But the bigger story is the reset behind the scenes: even after Costco delivered a first‑quarter fiscal 2026 earnings beat and posted mid‑single‑digit comparable sales growth, the stock has faced questions about valuation, membership

Stock Market Today

Corning stock price hits record close — what’s driving GLW and the next big test

Corning stock price hits record close — what’s driving GLW and the next big test

7 February 2026
Corning shares jumped 8.3% to a record $122.16 Friday, gaining 11% over two sessions amid strong demand for AI infrastructure stocks. The move follows a $6 billion optical fiber deal with Meta and upgraded company forecasts. Shares traded as high as $122.56 and rose 0.6% after hours. COO Avery Nelson sold 1,894 shares for tax withholding, retaining 66,050.
PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

7 February 2026
PepsiCo priced €2.5 billion in euro notes across four maturities, with settlement set for Feb. 11, according to an SEC filing. The company plans to use proceeds for general corporate purposes, including repaying commercial paper. Shares closed at $170.49 Friday, up 1.8%. PepsiCo is also cutting U.S. snack prices by up to 15% after consumer pushback.
Go toTop